Denmark, May 6 -- Navamedic ASA, a Nordic pharma company and trusted supplier of high-quality prescription, consumer health, and hospital products to hospitals and pharmacies, today announced it has launched Eroxon(R), a clinically proven over-the-counter topical treatment for the treatment of erectile dysfunction in men, in Denmark.The product launch marks the fourth launch of Eroxon(R) in the Nordics since Navamedic introduced the product to the Norwegian market in February 2024. As part of Navamedic's Consumer Health area, Eroxon(R) will be available to Danish consumers, without a prescription, across pharmacies.Ahead of the launch, Navamedic carried out a study through YouGov1. According to the study, more than 500,000 Danish men over t...